Ruqaya nangrejo

Prof. Ruqaya nangrejo

Physiology, Baqai Medical University, Karachi, Sindh, Pakistan
orcid
Professor of Physiology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Pakistan Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
IAIffat Ara Aziz
Iffat Ara Aziz
AFAsher Fawwad
Asher Fawwad
ISIftikhar Ahmed Siddiqui
Iftikhar Ahmed Siddiqui
KPKahkashan Perveen
Kahkashan Perveen
RNRuqaya nangrejo
Ruqaya nangrejo
ABAbdul Basit
Abdul Basit
As the state of hyperfibrinogenemia in diabetes patients occurs due to hyperglycemia which also activates the coagulative cascade ultimately stimulating hepatic fibrinogen synthesis and thus increases clotting factors and PAI-1 levels in the blood. Therefore, in present study our aim is to correlate between type of diabetes and plasma fibrinogen level and plasminogen activator inhibitor-1. This cross sectional study was conducted at Baqai Medical University (BMU) with the collaboration of Baqai Institute of Diabetology and Endocrinology, Karachi. Data was collected from 161 subjects, out of which 51 were control and 55 were subjects in each type 1 diabetes, type 2 diabetes simultaneously. Anthropometric measurements included measurement of weight, height, BMI and blood pressure which were done for each participant. Blood sugar levels and glycated hemoglobin, lipid profile, PAI-1 and fibrinogen were measured in cases and controls. Out of 161 subjects, 80 (49.7%) were male and 81 (50.3%) were female with mean age of 37.75±1.25 years. Fibrinogen level was significantly decreased in healthy subjects as compared to type 1 and type 2 diabetes subjects P-value<0.0001, however no significant difference was observed in fibrinogen level of type 1 diabetes subjects and type 2 diabetes subjects. Plasminogen activator inhibitor-1 of type 2 diabetes subjects was significantly increased as compared to type 1 diabetes subjects (P-value0.05). Since, fibrinogen and plasminogen activator inhibitor type 1 was increased in diabetes patients this predisposed them to increased risk of coronary artery disease, our study further supports the clinical observation that diabetes is a thrombophillic condition.

24 September 2021 in Journal of Pharmaceutical Research International
Verified
Journal Article
Closed access
PDF file
FMFaizah Mughal
Faizah Mughal
AKAshok Kumar
Ashok Kumar
JMJai Dev Maheshwari
Jai Dev Maheshwari
ABAli Nawaz Bijarani
Ali Nawaz Bijarani
TKTayyaba Kazmi
Tayyaba Kazmi
RNRuqaya nangrejo
Ruqaya nangrejo
Background: The menstrual cycle describes the healthy reproductive system of the women which is controlled by different hormones. Aim: The goal of the study is to evaluate the prevalence of irregular menstruation in different endocrine changes and to identify their association with the age of women in reproductive life. Methodology: It was a cross-sectional study conducted on women attending the gynecological clinic of Karachi from March 2019 to June 2019. Of the 165 women with different hormonal changes 100 presented with menstrual cycle abnormality. Results: Among the women with menstrual irregularities 51% women presented with insulin resistance, 23% with hyperandrogenism, 19% with hypothyroidism and 7% hyperprolactinemia. Age-related association was observed in menstrual irregularities women with insulin resistant and hyperandrogenism. Conclusion: Menstrual cycle is a physiological process, any irregularities in cycle can be caused by even minimal hormonal imbalance. As a result, it is critical to address endocrine abnormalities in order to improve women's reproductive health.

10 March 2025 in Anaesthesia, Pain & Intensive Care
Verified
Journal Article
Open access
PDF file
SRSaima Rehman
Saima Rehman
QAQamer Aziz
Qamer Aziz
IAIffat Ara Aziz
Iffat Ara Aziz
RNRuqaya nangrejo
Ruqaya nangrejo
IAIftikhar Ahmed
Iftikhar Ahmed
AFAsher Fawwad
Asher Fawwad
Background & objective: Recent research has identified various biomarkers in metabolic diseases, which can indicate the severity and the outcome of the disease. This study aimed to compare serum Apelin levels between obese and non-obese patients with type 2 diabetes mellitus (T2DM) and investigate their relationship with obesity and cardio-metabolic indicators. By analyzing these connections, the study attempted to clarify Apelin’s role in obesity-related cardio-metabolic risks and its potential as a biomarker for better T2DM management. Methodology: This cross-sectional study included a total of 200 patients, divided into two groups: 100 obese and 100 non-obese T2DM patients, and their anthropometric and clinical data, including weight, body mass index (BMI), waist and hip circumferences (WC and HC), and blood pressure, were collected. We measured serum Apelin, fasting blood sugar (FBS), hemoglobin A1C (HbA1c), and lipid profile, and analyzed correlations between Apelin levels with the study parameters. Results: Serum Apelin levels were significantly higher in obese T2DM patients compared to non-obese T2DM patients (P < 0.000). Apelin levels exhibited a positive but weak correlation with weight (r = 0.150), BMI (r = 0.384), WC (r = 0.331), and HC (r = 0.422). Diastolic blood pressure showed an average positive correlation with Apelin (r = 0.224). FBS levels were negatively correlated with Apelin (r = -0.214, P < 0.0001) while HbA1c and serum Apelin had a weak and statistically insignificant correlation (r = 0.064). Serum total cholesterol TC (r = 0.194) and triglycerides TG (r = 0.146) had weak positive correlations with Apelin, while High-Density Lipoproteins (HDL) exhibited a significant, negative correlation (r = -0.253). Conclusion: Elevated serum Apelin levels observed in obese T2DM patients indicate a potential compensatory mechanism in response to obesity-related complications. Further studies are warranted to elucidate the exact role of Apelin in the pathophysiology of T2DM, particularly in the context of obesity. Abbreviations: BMI: Body Mass Index, T2DM: type 2 diabetes mellitus, FBS: fasting blood sugar, HDL: High-Density Lipoproteins, HC: hip circumference, WC: waist circumference Keywords: Apelin; Diabetes Mellitus; Obesity; Cardiometabolic risks; Pakistan Citation: Rehman S, Aziz Q, Aziz IA, Nangrejo R, Ahmed I, Fawwad A. Comparative analysis of apelin levels in type 2 diabetes mellitus among the obese and non-obese population of Karachi, Pakistan. Anaesth. pain intensive care 2025;29(7):719-726. DOI: 10.35975/apic.v29i7.2966 Received: May 09, 2025; Revised: October 26, 2024; Accepted: January 01, 2025

31 August 2026 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
AIAzhar Iqbal
Azhar Iqbal
RNRuqaya nangrejo
Ruqaya nangrejo
MKMuhammad Noman Khan
Muhammad Noman Khan
QSQamar Aziz Siddiqui
Qamar Aziz Siddiqui
Objectives: To compare cardiac bridging integrator 1 (cBIN1) levels between healthy individuals and patients with heart failure (HF), and to assess changes in cBIN1 levels following therapeutic intervention to evaluate its potential as a diagnostic and prognostic biomarker. Methodology: A case-control study with three months follow-up was conducted in the Department of Physiology, Baqai University Hospital, Karachi, Pakistan, from June 2024 to November 2024. A total of 200 adults aged 40-70 years were recruited, comprising 50 healthy controls with left ventricular ejection fraction (LVEF ≥60%) and 150 patients with heart failure (HF): Heart failure with reduced, moderatly reduced and preserved ejection fraction, HFrEF (LVEF ≤40%), HFmrEF (LVEF 40-49%) and HFpEF (LVEF ≥50%). Enzyme linked immuno-essay (ELISA) was used to measure the plasma cBIN1 level at baseline. For the statistical analysis, ANOVA and t-tests, as well as post-hoc testing with significance at p<0.05, were used. Results: Mean plasma cBIN1 was 9.221±0.440 ng/mL in healthy controls, 1.193±0.059 in HFpEF, 1.009±0.063 in HFmrEF and 0.799±0.050 in HFrEF (p<0.001), with the lowest levels in HFrEF on post-hoc testing (p0.05). No significant change was observed after three months of follow-up (p=0.963). Conclusion: Plasma cBIN1 levels were significantly lower in patients with heart failure than in healthy controls, with the lowest levels observed in HFrEF. These findings suggest that cBIN1 may have value in stratifying HF severity and warrant evaluation in larger, multicenter cohorts.

28 July 2026 in Genes
Verified
Journal Article
Open access
PDF file
TKTayyaba Medical Kazmi
Tayyaba Medical Kazmi
RNRuqaya nangrejo
Ruqaya nangrejo
EAEraj Abbas
Eraj Abbas
NWNazish Waris
Nazish Waris
ISIftikhar Ahmed Siddiqui
Iftikhar Ahmed Siddiqui
PLPaul Laurance-Young
Paul Laurance-Young
Objective: The study was conducted to investigate the frequency of MED12 gene (rs5030619) mutations and to evaluate DNA methylation patterns in uterine leiomyomas among women at a tertiary care hospital in Karachi, Pakistan. Methods: In this cross-sectional study, 200 women with uterine fibroids and 50 controls were recruited from tertiary care hospitals after ethical approval. Baseline data and history were collected. Serum levels of estradiol, progesterone, and FSH were measured. Genomic DNA was extracted from fibroid and myometrial tissues and analyzed using allele-specific PCR for MED12 genotyping. DNA methylation profiling was conducted to evaluate epigenetic modifications. Statistical analyses were performed using the Statistical Package for social sciences (SPSS) version 27.0. Results: The majority of cases were aged 31–50 years, with 41.5% overweight and 24.5% obese. An increased WHR was observed in 65% of cases, compared to only 36% of controls. Serum estradiol, progesterone, and FSH levels were significantly higher in cases across all menstrual phases (p < 0.01). The MED12 A/C genotype was significantly associated with fibroid risk (OR = 11.72, 95% CI: 5.59–24.57, p < 0.001), and the C/C genotype conferred the highest risk (OR = 18.17, 95% CI: 4.00–82.54, p = 0.001). C allele was associated with increased disease susceptibility (OR = 4.65, 95% CI: 2.69–8.03, p < 0.001). Hyper-methylation was the most prevalent finding, observed in 125 cases of leiomyomas (69.4%). Multivariable logistic regression identified age (OR = 1.04, p = 0.012), BMI (OR = 1.09, p = 0.004), multiple fibroids (OR = 2.31, p = 0.005), intramural fibroid location (OR = 1.88, p = 0.041), and positive family history (OR = 2.74, p = 0.003) as significant independent predictors. Conclusions: Uterine leiomyomas may be influenced by a combination of hormonal, metabolic, genetic, and epigenetic factors. Overall findings suggest that MED12 C allele and A/C genotype variation was significantly associated with increased DNA methylation in uterine leiomyomas.

22 April 2022 in Journal of the Dow University of Health Sciences
Verified
Journal Article
Open access
PDF file
AMAtif Mahmood
Atif Mahmood
QAQamer Aziz
Qamer Aziz
RNRuqaya nangrejo
Ruqaya nangrejo
IAIftikhar Ahmed
Iftikhar Ahmed
SSSaleh Soomro
Saleh Soomro
IAIffat Ara
Iffat Ara
Objective: To investigate the polymorphism superoxide dismutase (SOD1) gene and its relationship with the development of cataracts in patients of Karachi.Methods: This was a case-control study carried out at different centers in Karachi, Pakistan between September 2019 and 2020. A single nucleotide polymorphism (SNP) at rs2070424(SOD1) locus was examined with polymerase chain reaction (PCR) using high resolution melting curve (HRM) technique in 250 cataract patients and 250 healthy control groups of similar age and gender.Results: Of 500 subjects, there were 250 cases and 250 controls. The mean age of the cataract patients (cases) was 43.97± 13.36 years. Among cases, 150 (60.0%) were males and 100 (40.0%) were females whereas in controls, 127 were males (50.8%) and 123 (49.2%) were females. A significant association of cataract was found with age (p value = 0.005), and smoking (p-value = 0.001). AG genotype has a smaller risk (OR=1.77, 95% CI 1.11 – 2.66, p-value= 0.006) associated with cataract while GG has a higher risk (OR = 2.83, 95% CI 1.71 – 4.68, p-value < 0.001). Further, calculation of allelic distribution revealed that the G allele was more prevalent in the cataract group 200 (61.7%) as compared to controls 124 (38.3%) (p-value=0.001). Conclusion: The significantly higher G allele frequency in the SOD1 gene at the rs2070424(SOD1) locus in the cataract group indicates that potential risk factors contribute to cataracts' development. This study contributes to the genetic profiling of cataract patients in the Pakistani population.